Cargando…

New open drug activity data at EBI

Detalles Bibliográficos
Autores principales:	Steinbeck, C, Al-Lazikani, B, Hermjakob, H, Overington, J, Thornton, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2009
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755535/ http://dx.doi.org/10.1186/1752-153X-3-S1-O3

Ejemplares similares

The EBI enzyme portal
por: Alcántara, Rafael, et al.
Publicado: (2013)

ChEBI: a chemistry ontology and database
por: de Matos, Paula, et al.
Publicado: (2010)

Expanding natural product chemistry resources at the EBI
por: Hastings, Janna, et al.
Publicado: (2013)

TEMBLOR – Perspectives of EBI Database Services
por: Hermjakob, Henning, et al.
Publicado: (2002)

libChEBI: an API for accessing the ChEBI database
por: Swainston, Neil, et al.
Publicado: (2016)

Providing open imaging data at scale: An EMBL-EBI perspective
por: Hartley, Matthew, et al.
Publicado: (2023)

The EBI RDF platform: linked open data for the life sciences
por: Jupp, Simon, et al.
Publicado: (2014)

The European Bioinformatics Institute (EMBL-EBI) in 2021
por: Cantelli, Gaia, et al.
Publicado: (2021)

Hepatitis C new drugs
por: Wedemeyer, H
Publicado: (2010)

The EBI Search engine: providing search and retrieval functionality for biological data from EMBL-EBI
por: Squizzato, Silvano, et al.
Publicado: (2015)

The EBI search engine: EBI search as a service—making biological data accessible for all
por: Park, Young M., et al.
Publicado: (2017)

EBIS scanner
Publicado: (1978)

CADDSuite – a workflow-enabled suite of open-source tools for drug discovery
por: Kohlbacher, Oliver
Publicado: (2012)

Workshop on EBIS and related topics
por: Klein, H, et al.
Publicado: (1977)

Drug anaphylaxis in children – data of the German-speaking anaphylaxis registry
por: Gernert, S, et al.
Publicado: (2013)

ChEBI in 2016: Improved services and an expanding collection of metabolites
por: Hastings, Janna, et al.
Publicado: (2016)

Mobilisation of neural structures opens up new possibilities for idiopathic scoliosis treatment
por: Leal, E Santos
Publicado: (2012)

Computational metabolomics – a field at the boundaries of cheminformatics and bioinformatics
por: Steinbeck, Christoph, et al.
Publicado: (2011)

Chemical ontologies: what are they, what are they for and what are the challenges
por: Hastings, Janna, et al.
Publicado: (2011)

EBI metagenomics—a new resource for the analysis and archiving of metagenomic data
por: Hunter, Sarah, et al.
Publicado: (2014)

S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL
por: Heeney, M, et al.
Publicado: (2022)

Estimating the window of selection of antimalarial drugs using field data
por: Winter, Katherine, et al.
Publicado: (2012)

EMBL-EBI and Bioinformatics
por: NEWHOUSE, Steven
Publicado: (2014)

The ion cooling in EBIS
por: Shirkov, G D, et al.
Publicado: (1992)

The EMBL-EBI channel
por: McEntyre, Jo, et al.
Publicado: (2016)

Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study
por: Aróstegui, JI, et al.
Publicado: (2015)

S103: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE PKR ACTIVATOR ETAVOPIVAT (FT-4202) IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE
por: Lal, A., et al.
Publicado: (2022)

New drugs for the control and elimination of malaria: a snapshot of the pipeline
por: Wells, Timothy NC
Publicado: (2012)

O023: Combining electronic contacts data and virological data for studying the transmission of infections at hospital
por: Payet, C, et al.
Publicado: (2013)

Evidence-Based Intervention (EBI) Mapping: a systematic approach to understanding the components and logic of EBIs
por: Walker, Timothy J., et al.
Publicado: (2022)

Antimalarial drug discovery: targeting the hypnozoite for new radical curative agent
por: Yeung, Bryan
Publicado: (2012)

Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data
por: Ruperto, N, et al.
Publicado: (2014)

The Retrovirology open access experience
por: Jeang, Kuan-Teh
Publicado: (2011)

Integrating logic-based machine learning and virtual screening to discover new drugs
por: Reynolds, Christopher R, et al.
Publicado: (2012)

Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014)

Drug resistance patterns in new and previously treated patients with tuberculosis presenting to a tertiary care center in southern India
por: Udaykumar, Anto J, et al.
Publicado: (2014)

An audit of out of hours MRI scanning at a tertiary care referral hospital
por: Alnafisee, S, et al.
Publicado: (2015)

Postpartum evolution of newborns to mothers addicted to “new drugs” and recently diagnosed with HIV infection
por: Ungurianu, Rodica, et al.
Publicado: (2013)

Lersivirine: a new NNRTI active across HIV-1 subtypes with a unique resistance profile
por: Mori, J, et al.
Publicado: (2010)

Strengthening immunisation supply chain systems through the GAVI Alliance Immunisation Supply Chain Strategy
por: Brownlow, Kaleb, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c3rb2ooiafaoumjcknmvgn0saf